Exact Mass: 424.0875
Exact Mass Matches: 424.0875
Found 61 metabolites which its exact mass value is equals to given mass value 424.0875,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Hydroxyethyl biscoumacetate
Ethyl 2-(4,7-dihydroxy-2-oxo-2H-chromen-3-yl)-2-(4-hydroxy-2-oxo-2H-chromen-3-yl)acetic acid
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
Zibotentan
trans,trans-2(4-Methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid
Zibotentan is an orally available selective antagonist of the endothelin-A (ET-A) receptor with potential antineoplastic activity. Zibotentan binds selectively to the ET-A receptor, thereby inhibiting endothelin-mediated mechanisms that promote tumor cell proliferation. Zibotentan (ZD4054) is a potent, selective and orally active endothelin A (ETA) receptor antagonist with a Ki of 13 nM. Zibotentan has no inhibitory effect on ETB. Zibotentan has anticancer effects and can be used for castration-resistant prostate cancer (CRPC) research. Zibotentan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=186497-07-4 (retrieved 2024-10-09) (CAS RN: 186497-07-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
6-(3,4-Dihydroxyphenyl)-6a,12b-dihydro-3,10,11,12-tetrahydroxy-[2]benzopyrano[3,4-c]benzopyran-8(6H)-one
6-(3,4-Dihydroxyphenyl)-6a,12b-dihydro-3,10,11,12-tetrahydroxy-[2]benzopyrano[3,4-c]benzopyran-8(6H)-one
(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano<3,4-c>-2-benzopyran-1-one|(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano[3,4-c]-2-benzopyran-1-one|(2R,3S,4S)-6-(3,4-Dihydroxyphenyl)-6alpha,12b-dihydro-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8(6H)-one|(6R,6aS,12bR)-3,10,11,12-tetrahydroxy-6-(3,4-dihydroxyphenyl)-6a,12b-dihydro[1]benzopyrano[3,4-c][2]benzopyran-8(6H)-one
(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano<3,4-c>-2-benzopyran-1-one|(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano[3,4-c]-2-benzopyran-1-one|(2R,3S,4S)-6-(3,4-Dihydroxyphenyl)-6alpha,12b-dihydro-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8(6H)-one|(6R,6aS,12bR)-3,10,11,12-tetrahydroxy-6-(3,4-dihydroxyphenyl)-6a,12b-dihydro[1]benzopyrano[3,4-c][2]benzopyran-8(6H)-one
(2R,3S)-trans-8-(2-carbonyl-4,5-dihydroxy)-phenyl-7,7-lactonecatechin|catechin lactone A
(2R,3S)-trans-8-(2-carbonyl-4,5-dihydroxy)-phenyl-7,7-lactonecatechin|catechin lactone A
(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzofuran-3-yloxy)-6H-dibenzopyran-6-one|(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzo[b]furan-3-yloxy)-6H-dibenzo[b,d]pyran-6-one|5-Hyddroxy-9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one
(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzofuran-3-yloxy)-6H-dibenzopyran-6-one|(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzo[b]furan-3-yloxy)-6H-dibenzo[b,d]pyran-6-one|5-Hyddroxy-9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one
Cys Cys Cys Pro
(2S)-1-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Cys Cys Pro Cys
(2R)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid
Cys Pro Cys Cys
(2R)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid
Pro Cys Cys Cys
(2R)-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid
3-(2-(2,4-DIFLUOROPHENOXY)-6-OXO-6H-PYRIDO[1,2-B]PYRIDAZIN-5-YL)-4-METHOXYBENZOIC ACID
3-(2-(2,4-DIFLUOROPHENOXY)-6-OXO-6H-PYRIDO[1,2-B]PYRIDAZIN-5-YL)-4-METHOXYBENZOIC ACID
alpha-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-dihydro-4-oxoquinazoline-2-acetonitrile
alpha-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-dihydro-4-oxoquinazoline-2-acetonitrile
1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran
1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran
ROS Probe, HPF
ROS Probe, HPF
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
Zibotentan
Zibotentan (ZD4054)
C28313 - Endothelin Receptor Antagonist Zibotentan (ZD4054) is a potent, selective and orally active endothelin A (ETA) receptor antagonist with a Ki of 13 nM. Zibotentan has no inhibitory effect on ETB. Zibotentan has anticancer effects and can be used for castration-resistant prostate cancer (CRPC) research[1][2].
(2,6-Difluorophenyl)-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1-piperazinyl]methanone
(2,6-Difluorophenyl)-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1-piperazinyl]methanone
[4-(2,6-Difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone
[4-(2,6-Difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone
1-(2-Furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea
1-(2-Furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea
[4-[[[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]thio]methyl]phenyl]-hydroxy-methylsulfonium
[4-[[[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]thio]methyl]phenyl]-hydroxy-methylsulfonium
(5E)-3-(Furan-2-ylmethyl)-5-[[1-(4-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
(5E)-3-(Furan-2-ylmethyl)-5-[[1-(4-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
2-(2-Oxo-9-sulooxy-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl 3-methylbut-2-enoate
2-(2-Oxo-9-sulooxy-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl 3-methylbut-2-enoate
ML375
ML375
ML375 (VU0483253) is a potent, highly selective, brain-penetrant and orally active M5 mAChR negative allosteric modulator (NAM) with IC50s of 300 nM and 790 nM for human and rat M5, respectively. ML375 is inactive at human and rat M1-M4[1].
9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one
9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one
4-(acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl acetate
4-(acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl acetate
{3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid
{3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid
2-{2-[2-(2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl)-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl}-1,3-thiazole
2-{2-[2-(2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl)-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl}-1,3-thiazole
1,5-dimethyl (2s,4r)-2,4-dihydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]pentanedioate
1,5-dimethyl (2s,4r)-2,4-dihydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]pentanedioate
methyl (1r,3ar,5s,9br)-7-bromo-5,6-dihydroxy-1-isopropyl-3a,8-dimethyl-4-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-5-carboxylate
methyl (1r,3ar,5s,9br)-7-bromo-5,6-dihydroxy-1-isopropyl-3a,8-dimethyl-4-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-5-carboxylate
1,5-dimethyl (2s,4r)-2,4-dihydroxy-2-[(2r)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]pentanedioate
1,5-dimethyl (2s,4r)-2,4-dihydroxy-2-[(2r)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]pentanedioate
{3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid
{3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid
methyl 7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-5-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-4-carboxylate
methyl 7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-5-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-4-carboxylate
2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylic acid
2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylic acid
2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylic acid
2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylic acid
(2z)-3-(3,4-dihydroxyphenyl)-2-{6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoic acid
(2z)-3-(3,4-dihydroxyphenyl)-2-{6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoic acid
methyl 7-bromo-5,6-dihydroxy-1-isopropyl-3a,8-dimethyl-4-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-5-carboxylate
methyl 7-bromo-5,6-dihydroxy-1-isopropyl-3a,8-dimethyl-4-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-5-carboxylate
[(6r)-3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl]acetic acid
[(6r)-3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl]acetic acid
2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylic acid
2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylic acid
2-[(4s)-2-[(4r)-2-[(4r)-2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl]-1,3-thiazole
2-[(4s)-2-[(4r)-2-[(4r)-2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl]-1,3-thiazole
(1r,9r,10s)-9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one
(1r,9r,10s)-9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one
3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoic acid
3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoic acid
5-hydroxy-3,4-bis(4-hydroxyphenyl)-7-phenyl-1-benzofuran-2,6-dione
5-hydroxy-3,4-bis(4-hydroxyphenyl)-7-phenyl-1-benzofuran-2,6-dione
[(6r)-3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl]acetic acid
[(6r)-3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl]acetic acid
